Lotus Pharmaceutical Co., Ltd. (TPE:1795)
253.50
-14.50 (-5.41%)
At close: Mar 9, 2026
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 66.67 billion as of March 9, 2026. Its market cap has decreased by -10.13% in one year.
Market Cap
66.67B
Enterprise Value
73.41B
Revenue
18.66B
Ranking
n/a
PE Ratio
14.05
Stock Price
253.50
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 66.67B, an increase of 625.62%. That is a compound annual growth rate of 18.66%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 60.15B |
| Center Laboratories | 36.54B |
| TTY Biopharm Company | 20.74B |
| PharmaEssentia | 259.07B |
| Grape King Bio | 17.85B |
| ScinoPharm Taiwan | 17.12B |
| Synmosa Biopharma | 15.92B |
| YungShin Global Holding | 14.46B |